GoodRx (GDRX) Institutional Ownership

63.77% of GoodRx's stock is owned by institutional investors. Learn more on GDRX's institutional investor holdings.

Of the 171 institutional investors that purchased GoodRx's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: LSV Asset Management ($2.83M), Rubric Capital Management LP ($2.56M), American Century Companies Inc. ($2.38M), 8 Knots Management LLC ($1.84M), Prescott Group Capital Management L.L.C. ($1.82M), Point72 Asset Management L.P. ($1.63M), and Northwestern Mutual Wealth Management Co. ($1.50M).

Institutional investors have bought a total of 20,384,638 shares in the last 24 months. This purchase volume represents approximately $72.85M in transactions.

Of the 41 institutional investors that sold GoodRx's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Lakewood Capital Management LP ($2.67M), Ameriprise Financial Inc. ($934.35K), Raymond James Financial Inc. ($522.21K), State Street Corp ($479.96K), JPMorgan Chase & Co. ($341.24K), Renaissance Technologies LLC ($258.40K), and Two Sigma Investments LP ($236.00K).

Institutional investors have sold a total of 7,584,517 shares in the last 24 months. This volume of shares sold represents approximately $29.93M in transactions.